Stocklytics Platform
Asset logo for symbol MLTX
MoonLake Immunotherapeutics
MLTX52
$52.67arrow_drop_up1.07%$0.56
Asset logo for symbol MLTX
MLTX52

$52.67

arrow_drop_up1.07%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

MoonLake Immunotherapeutics (MLTX) Stocklytics Forecast

MoonLake Immunotherapeutics (MLTX) is an emerging company in the field of immunotherapy, focused on developing innovative treatments for various types of cancer. With its cutting-edge technologies and promising pipeline, MLTX has garnered significant attention from investors and analysts alike. As a result, many are eager to know the future prospects of MLTX stock and its potential for growth.
When it comes to predicting the stock price of MLTX, various factors need to be taken into consideration. One approach is to utilize AI-based algorithms that analyze historical price data, market trends, and other relevant information to generate forecasts. These machine learning prediction models can provide valuable insights into the potential price movements of MLTX stock.
add MoonLake Immunotherapeutics to watchlist

Keep an eye on MoonLake Immunotherapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for MoonLake Immunotherapeutics (MLTX) stock?

Analysts have set a target price of $74.39 for MoonLake Immunotherapeutics (MLTX), based on forecasts from 23 analysts. The predicted price range extends from a high of $92 to a low of $41. This represents a potential increase of up to 74.67% and a decrease of -22.16% from the current price of $52.67. These forecasts are as of 2023 Jun 21.
help

What are the analyst ratings for MoonLake Immunotherapeutics (MLTX) stock?

The analyst ratings for MoonLake Immunotherapeutics (MLTX) are distributed as follows: 13 analysts recommend buying, 3 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 16 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering MoonLake Immunotherapeutics.
help

What is the AI price prediction for MoonLake Immunotherapeutics (MLTX) stock?

At present, there is no AI or machine-learning-based price prediction available for MoonLake Immunotherapeutics (MLTX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level